Skip to content
Oxytetracycline
Oxy-kesso-tetra, Terra-cortril, Terramycin (oxytetracycline) is a small molecule pharmaceutical. Oxytetracycline was first approved as Terra-cortril on 1982-01-01. It is used to treat acne vulgaris, bacterial infections, borrelia infections, chlamydia infections, and gonorrhea amongst others in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
urogenital diseasesD000091642
skin and connective tissue diseasesD017437
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Oxytetracycline
Tradename
Company
Number
Date
Products
TERRAMYCINMylanN-050287 DISCN1982-01-01
1 products
Hide discontinued
Oxytetracycline hydrochloride
Tradename
Company
Number
Date
Products
TERRAMYCINMylanN-050286 DISCN1982-01-01
2 products
Hide discontinued
Oxytetracycline hydrochloride
+
Polymyxin b sulfate
Tradename
Company
Number
Date
Products
TERRAMYCIN W/ POLYMYXIN B SULFATECasper PharmaN-061015 DISCN1982-01-01
1 products
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
acne vulgarisEFO_0003894D000152L70
bacterial infections—D001424A49
borrelia infectionsEFO_1000842D001899—
chlamydia infectionsEFO_0007205D002690A74.9
gonorrheaDOID_7551D006069A54
gram-positive bacterial infections—D016908—
klebsiella infectionsEFO_1001353D007710—
mycoplasma infections—D009175—
protozoan infections—D011528B50-B64
psittacosisEFO_0007410D009956A70
Show 2 more
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
D: Dermatologicals
— D06: Antibiotics and chemotherapeutics for dermatological use
— D06A: Antibiotics for topical use
— D06AA: Tetracycline and derivatives, topical antibiotics
— D06AA03: Oxytetracycline
G: Genito urinary system and sex hormones
— G01: Gynecological antiinfectives and antiseptics
— G01A: Antiinfectives and antiseptics, excl. combinations with corticosteroids
— G01AA: Antibiotics, gynecological
— G01AA07: Oxytetracycline
J: Antiinfectives for systemic use
— J01: Antibacterials for systemic use
— J01A: Tetracycline antibiotics
— J01AA: Tetracyclines
— J01AA06: Oxytetracycline
— J01AA56: Oxytetracycline, combinations
S: Sensory organ drugs
— S01: Ophthalmologicals
— S01A: Antiinfective ophthalmologics
— S01AA: Antibiotics, ophthalmologic
— S01AA04: Oxytetracycline
HCPCS
Code
Description
J2460
Injection, oxytetracycline hcl, up to 50 mg
Clinical
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameOXYTETRACYCLINE
INNoxytetracycline
Description
Oxytetracycline is a tetracycline used for treatment of infections caused by a variety of Gram positive and Gram negative microorganisms including Mycoplasma pneumoniae, Pasteurella pestis, Escherichia coli, Haemophilus influenzae (respiratory infections), and Diplococcus pneumoniae. It has a role as an antibacterial drug, a protein synthesis inhibitor, an antimicrobial agent, an anti-inflammatory drug and a bacterial metabolite. It is a tautomer of an oxytetracycline zwitterion.
Classification
Small molecule
Drug classantibiotics (tetracycline derivatives)
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3[C@H](O)[C@@H]12
Identifiers
PDB—
CAS-ID79-57-2
RxCUI1545999
ChEMBL IDCHEMBL1517
ChEBI ID27701
PubChem CID54675779
DrugBankDB00595
UNII IDSLF0D9077S (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 12,674 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
0 adverse events reported
View more details